Skip to main content
Study

Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.

Gilbar P, Chambers CR, Larizza M. Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists. J Oncol Pharm Pract. 2015;21(1):10-8. doi:10.1177/1078155213517729.

Save
Print
February 26, 2014
Gilbar P, Chambers CR, Larizza M. J Oncol Pharm Pract. 2015;21(1):10-8.

The chemotherapy drug vincristine almost always causes fatal toxicity if it is incorrectly administered intrathecally (via spinal injection) rather than intravenously. This hazard is well publicized, but accidental administration of intrathecal vincristine continues to occur. This survey of oncology pharmacists found that many pharmacies still lack appropriate safeguards to prevent such errors.

Save
Print
Cite
Citation

Gilbar P, Chambers CR, Larizza M. Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists. J Oncol Pharm Pract. 2015;21(1):10-8. doi:10.1177/1078155213517729.